Laylay, Wilfredo D.
HRN: 16-14-51 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2026
CEFTRIAXONE 1G (VIAL)
03/04/2026
03/11/2026
IV
2g
OD
Decompensated Liver Disease; Massive Ascites
Checking Initial Appropriateness
03/05/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/05/2026
03/12/2026
IV
4.5g
Q8H
Intra Abdominal
Checking Initial Appropriateness